⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4707971 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL31513934 | 0.98 | — | — | |
| SCHEMBL31570729 | 0.91 | — | — | |
| SCHEMBL31570726 | 0.91 | — | — | |
| SCHEMBL10430740 | 0.83 | — | — | |
| SCHEMBL11237977 | 0.81 | — | — | |
| SCHEMBL11237979 | 0.81 | — | — | |
| SCHEMBL12505724 | 0.80 | — | — | |
| SCHEMBL12505722 | 0.80 | — | — | |
| SCHEMBL5155976 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1687325-A4 | NOVEL SEQUENCES ENCODING HEPATITIS C VIRUS GLYCOPROTEINS | PROGENICS PHARM INC (US) | 2008-11-12 | — | — | EP | disclosed |
| EP-1733057-A2 | L-SIGN POLYMORPHISMS AND METHODS INVOLVING USE OF SAME | PROGENICS PHARMACEUTICALS, INC. (US) | 2006-12-20 | — | — | EP | disclosed |
| EP-1687325-A2 | NOVEL SEQUENCES ENCODING HAPATITIS C VIRUS GLYCOPROTEINS | PROGENICS PHARMACEUTICALS, INC. (US) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005100601-A2 | L-SIGN POLYMORPHISMS AND METHODS INVOLVING USE OF SAME | PROGENICS PHARMACEUTICALS, INC. (US) | 2005-10-27 | — | — | WO | disclosed |
| WO-2005047481-A2 | NOVEL SEQUENCES ENCODING HAPATITIS C VIRUS GLYCOPROTEINS | PROGENICS PHARMACEUTICALS, INC. (US) | 2005-05-26 | — | — | WO | disclosed |